Below is an interview conducted at the 2014 event with Ira Pastan, M.D., Co-Chief Laboratory of Molecular Biology, National Cancer Institute. At the event, Dr. Pastan presented "Recombinant Immunotoxins: From Conception to Clinical Reality in Leukemia and Mesothelioma"
Want to hear more from experts like Dr. Pastan? Then join us at the 2015 Antibody Engineering & Therapeutics event. Register today at save $550 when you use the code D15172BLOG.
See you in San Diego!
Share this article with your social network, just click below to share now!
|
|
No comments :
Post a Comment